Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model-Reference-Cited by-同舟云学术

Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model

Published:2016-10-25 Issue:1 Volume:131 Page:49-58
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Cikankowitz Annabelle,Clavreul Anne,Tétaud Clément,Lemaire Laurent,Rousseau Audrey,Lepareur Nicolas,Dabli Djamel,Bouchet Francis,Garcion Emmanuel,Menei Philippe,Couturier Olivier,Hindré François

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-016-2289-4.pdf

Reference46 articles.

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466

3. Vanpouille-Box C, Hindre F (2012) Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity. Front Oncol 2:136

4. Oh DS, Adamson DC, Kirkpatrick JP (2012) Targeted radiotherapy for malignant gliomas. Curr Drug Discov Technol 9(4):268–279

5. Barani IJ, Larson DA (2015) Radiation therapy of glioblastoma. Cancer Treat Res 163:49–73

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma;Journal of Neuro-Oncology;2024-08-24

2. Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice;eBioMedicine;2024-07

3. Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood–brain barrier;Acta Pharmaceutica Sinica B;2024-06

4. Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape;EJNMMI Radiopharmacy and Chemistry;2024-05-04

5. Nano Yttrium-90 and Rhenium-188 production through medium medical cyclotron and research reactor for therapeutic usages: A Simulation study;Nuclear Engineering and Technology;2023-05